Background
Results
Description of TB cases
HIV uninfected (n = 4013) | HIV infected (n = 10,379) | HIV status not recorded (n = 1817) | Total (n = 16,209) | |
---|---|---|---|---|
Sexa
| ||||
Data available | 4013 (100.00) | 10,379 (100.00) | 1817 (100.00) | 16,209 (100.00) |
Sex female | 1380 (34.39) | 5798 (55.86) | 639 (35.17) | 7817 (48.23) |
Age | ||||
Data available | 4012 (99.98) | 10,378 (99.99) | 1817 (100.00) | 16,207 (99.99) |
Median age (IQR) | 32 (23–46) | 33 (28–40) | 31 (24–43) | 33 (26–41) |
<25 | 1380 (34.4) | 1587 (15.29) | 578 (31.81) | 3545 (21.87) |
25–35 | 907 (22.61) | 4636 (44.67) | 538 (29.61) | 6081 (37.52) |
35–45 | 690 (17.2) | 2900 (27.94) | 333 (18.33) | 3923 (24.21) |
45–60 | 764 (19.04) | 1164 (11.22) | 278 (15.3) | 2206 (13.61) |
>60 | 271 (6.75) | 91 (0.88) | 90 (4.95) | 452 (2.79) |
Anatomic site of TB | ||||
Data available | 4013 (100.00) | 10,379 (100.00) | 1817 (100.00) | 16,209 (100.00) |
Pulmonary | 3358 (83.68) | 6805 (65.57) | 1465 (80.63) | 11,628 (71.74) |
Extra-pulmonary | 543 (13.53) | 2726 (26.26) | 292 (16.07) | 3561 (21.97) |
Both | 112 (2.79) | 848 (8.17) | 60 (3.30) | 1020 (6.29) |
Duration of TB treatment | ||||
Data available | 4013 (100.00) | 10,379 (100.00) | 1817 (100.00) | 16,209 (100.00) |
Median duration (IQR) | 168 (164–194) | 168 (161–219) | 167 (161–187) | 168 (163–209) |
Retreatment for TB | ||||
Data available | 4013 (100.00) | 10,379 (100.00) | 1817 (100.00) | 16,209 (100.00) |
Retreated case | 1001 (24.94) | 3332 (32.10) | 469 (25.81) | 4802 (29.63) |
TB smear results | ||||
Data available | 4013 (100.00) | 10,379 (100.00) | 1817 (100.00) | 16,209 (100.00) |
Smear negative | 972 (24.22) | 4773 (45.99) | 528 (29.06) | 6273 (38.70) |
Smear positive | 2716 (67.68) | 4032 (38.85) | 1103 (60.70) | 7851 (48.44) |
No smear performed | 325 (8.10) | 1574 (15.17) | 186 (10.24) | 2085 (12.86) |
Outcome | ||||
Data available | 4013 (100.00) | 10,379 (100.00) | 1817 (100.00) | 16,209 (100.00) |
Alive | 3237 (80.66) | 7813 (75.28) | 1333 (73.36) | 12,383 (76.40) |
Dead | 132 (3.29) | 641 (6.18) | 78 (4.29) | 851 (5.25) |
Lost to follow-up | 405 (10.09) | 1079 (10.40) | 210 (11.56) | 1694 (10.45) |
Transferred out | 137 (3.41) | 493 (4.75) | 124 (6.82) | 754 (4.65) |
Not known | 102 (2.54) | 353 (3.40) | 72 (3.96) | 527 (3.25) |
CD4 count | ||||
Data available | – | 6433 (61.98) | – | – |
Median CD4 count (IQR) | – | 146 (65–266) | – | – |
TMP-SMX during TB treatment | ||||
Data available | – | 10,012 (96.46) | – | – |
TMP-SMX during TB treatment | – | 9520 (95.09) | – | – |
ART during TB treatment | ||||
Data available | – | 8942 (86.15) | – | – |
ART during TB treatment | – | 2614 (29.23) | – | – |
Predictors of death
Crude | Adjusted | Adjusted (selected by AIC*) | |||
---|---|---|---|---|---|
HR (95 % CI) | p value | HR (95 % CI) | p value | HR (95 % CI) | |
Sex female | 1.05 (0.91–1.20) | 0.51 | 1.08 (0.94–1.24) | 0.28 | |
Age | |||||
<25 | Reference | Reference | Reference | ||
25–35 | 1.88 (1.42–2.48) | 0.00 | 1.53 (1.15–2.03) | 0.00 | 1.52 (1.14–2.01) |
35–45 | 2.37 (1.78–3.14) | 0.00 | 1.93 (1.45–2.58) | 0.00 | 1.90 (1.43–2.53) |
45–60 | 3.54 (2.66–4.72) | 0.00 | 3.25 (2.42–4.35) | 0.00 | 3.20 (2.40–4.27) |
>60 | 6.54 (4.65–9.19) | 0.00 | 7.22 (5.11–10.22) | 0.00 | 7.22 (5.11–10.19) |
Anatomic site of TB | |||||
Pulmonary | Reference | Reference | Reference | ||
Extra-pulmonary | 1.38 (1.18–1.62) | 0.00 | 1.20 (0.99–1.45) | 0.06 | 1.29 (1.10–1.51) |
Both | 1.62 (1.27–2.06) | 0.00 | 1.45 (1.14–1.85) | 0.00 | 1.46 (1.15–1.86) |
Prior TB | 1.28 (1.11–1.49) | 0.00 | 1.16 (1.00–1.35) | 0.05 | 1.16 (1.00–1.34) |
HIV infected | 1.82 (1.51–2.20) | 0.00 | 1.94 (1.58–2.40) | 0.00 | 2.00 (1.63–2.46) |
TB smear result | |||||
Smear negative | Reference | Reference | |||
Smear positive | 0.73 (0.63–0.84) | 0.00 | 0.93 (0.79–1.10) | 0.41 | |
No smear performed | 1.11 (0.91–1.36) | 0.31 | 1.08 (0.87–1.34) | 0.47 |
Crude | Adjusted | Adjusted (selected by AIC*) | |||
---|---|---|---|---|---|
HR (95 % CI) | p value | HR (95 % CI) | p value | HR (95 % CI) | |
Sex female | 0.98 (0.85–1.14) | 0.84 | 1.24 (1.06–1.45) | 0.01 | 1.23 (1.06–1.44) |
Age | |||||
<25 | Reference | Reference | Reference | ||
25–35 | 1.25 (0.92–1.68) | 0.15 | 1.24 (0.92–1.68) | 0.17 | 1.25 (0.92–1.70) |
35–45 | 1.58 (1.16–2.14) | 0.00 | 1.60 (1.17–2.18) | 0.00 | 1.62 (1.19–2.21) |
45–60 | 2.39 (1.73–3.29) | 0.00 | 2.50 (1.80–3.46) | 0.00 | 2.54 (1.83–3.52) |
>60 | 4.72 (2.99–7.44) | 0.00 | 4.79 (3.00–7.65) | 0.00 | 4.80 (3.00–7.66) |
Anatomic site of TB | |||||
Pulmonary | Reference | Reference | |||
Extra-pulmonary | 1.16 (0.98–1.38) | 0.09 | 1.14 (0.93–1.41) | 0.21 | |
Both | 1.44 (1.12–1.85) | 0.01 | 1.29 (1.00–1.68) | 0.05 | |
Prior TB | 1.12 (0.95–1.32) | 0.18 | 1.16 (0.98–1.37) | 0.09 | |
TB smear result | |||||
Smear negative | Reference | Reference | |||
Smear positive | 0.98 (0.83–1.16) | 0.83 | 1.07 (0.89–1.28) | 0.47 | |
No smear performed | 1.16 (0.93–1.45) | 0.18 | 1.08 (0.85–1.36) | 0.54 | |
CD4 count | |||||
<50 | Reference | Reference | Reference | ||
50–100 | 0.79 (0.61–1.02) | 0.07 | 0.79 (0.60–1.02) | 0.07 | 0.78 (0.60–1.01) |
100–200 | 0.55 (0.41–0.75) | 0.00 | 0.54 (0.40–0.71) | 0.00 | 0.53 (0.40–0.71) |
200–350 | 0.47 (0.37–0.61) | 0.00 | 0.43 (0.34–0.56) | 0.00 | 0.43 (0.33–0.55) |
350+ | 0.28 (0.18–0.43) | 0.00 | 0.24 (0.16–0.37) | 0.00 | 0.24 (0.16–0.37) |
TMP-SMX chemoprophylaxis | 1.01 (0.69–1.46) | 0.96 | 0.88 (0.60–1.29) | 0.52 | |
ART during TB treatment | 0.76 (0.64–0.91) | 0.00 | 0.60 (0.50–0.72) | 0.00 | 0.61 (0.51–0.73) |
Crude | Adjusted | Adjusted (selected by AIC*) | |||
---|---|---|---|---|---|
HR (95 % CI) | p value | HR (95 % CI) | p value | HR (95 % CI) | |
Sex female | 0.80 (0.56–1.15) | 0.23 | 0.83 (0.58–1.19) | 0.32 | |
Age, years | |||||
<25 | Reference | Reference | Reference | ||
25–35 | 3.01 (1.35–6.68) | 0.01 | 2.84 (1.28–6.30) | 0.01 | 2.91 (1.31–6.45) |
35–45 | 3.93 (1.73–8.96) | 0.00 | 3.53 (1.55–8.05) | 0.00 | 3.63 (1.59–8.26) |
45–60 | 9.58 (4.56–20.11) | 0.00 | 7.75 (3.65–16.42) | 0.00 | 7.93 (3.74–16.79) |
>60 | 20.38 (9.57–43.37) | 0.00 | 16.14 (7.52–34.63) | 0.00 | 16.24 (7.57–34.85) |
Anatomic site of TB | |||||
Pulmonary | Reference | Reference | |||
Extra-pulmonary | 2.18 (1.48–3.21) | 0.00 | 1.38 (0.85–2.22) | 0.19 | |
Both | 1.48 (0.60–3.66) | 0.40 | 1.23 (0.49–3.06) | 0.66 | |
Prior TB | 1.94 (1.35–2.78) | 0.00 | 1.41 (0.97–2.04) | 0.07 | 1.39 (0.96–2.01) |
TB smear result | |||||
Smear negative | Reference | Reference | Reference | ||
Smear positive | 0.36 (0.25–0.52) | 0.00 | 0.52 (0.35–0.78) | 0.00 | 0.47 (0.33–0.68) |
No smear performed | 0.88 (0.50–1.54) | 0.64 | 0.78 (0.43–1.40) | 0.40 | 0.86 (0.49–1.51) |
<45 years of age | ≥45 years of age | |||
---|---|---|---|---|
aHR (95 % CI) | p value | aHR (95 % CI) | p value | |
Sex female | 0.98 (0.83–1.16) | 0.802 | 1.11 (0.86–1.44) | 0.423 |
Anatomic site of TB | ||||
Pulmonary | Reference | Reference | ||
Extra-pulmonary | 1.16 (0.92–1.47) | 0.213 | 1.20 (0.84–1.69) | 0.313 |
Both | 1.52 (1.14–2.01) | 0.004 | 1.21 (0.72–2.05) | 0.473 |
Prior TB | 1.10 (0.92–1.33) | 0.299 | 1.31 (1.01–1.70) | 0.042 |
HIV infected | 3.16 (2.34–4.27) | <0.001 | 1.18 (0.87–1.59) | 0.282 |
TB smear result | ||||
Smear negative | Reference | Reference | ||
Smear positive | 0.99 (0.81–1.21) | 0.904 | 0.76 (0.56–1.02) | 0.068 |
No smear performed | 1.21 (0.94–1.56) | 0.142 | 0.87 (0.57–1.31) | 0.501 |
<45 years | ≥45 years | |||
---|---|---|---|---|
aHR (95 % CI) | p value | aHR (95 % CI) | p value | |
Sex female | 1.10 (0.92–1.31) | 0.310 | 1.44 (1.04–2.01) | 0.030 |
Anatomic site of TB | ||||
Pulmonary | Reference | Reference | ||
Extra-pulmonary | 1.14 (0.89–1.46) | 0.273 | 1.05 (0.66–1.66) | 0.838 |
Both | 1.33 (1.00–1.80) | 0.052 | 1.09 (0.59 – 2.01) | 0.775 |
Prior TB | 1.13 (0.93–1.37) | 0.234 | 1.39 (0.98–1.97) | 0.066 |
TB smear result | ||||
Smear negative | Reference | Reference | ||
Smear positive | 1.08 (0.87–1.33) | 0.471 | 0.94 (0.63–1.39) | 0.741 |
No smear performed | 1.16 (0.89–1.52) | 0.262 | 0.81 (0.48–1.39) | 0.447 |
CD4 count | ||||
<50 | Reference | Reference | ||
50–100 | 0.76 (0.57–1.02) | 0.065 | 0.92 (0.54–1.59) | 0.771 |
100–200 | 0.51 (0.37–0.70) | <0.001 | 0.62 (0.38–1.04) | 0.068 |
200–350 | 0.44 (0.33–0.58) | <0.001 | 0.40 (0.23–0.70) | 0.002 |
350+ | 0.23 (0.15–0.37) | <0.001 | 0.29 (0.13–0.67) | 0.005 |
TMP-SMX chemoprophylaxis | 0.83 (0.54–1.27) | 0.393 | 0.96 (0.30–3.04) | 0.936 |
ART during TB treatment | 0.67 (0.44–0.83) | <0.001 | 0.44 (0.27–0.72) | 0.001 |
<45 years | ≥45 years | |||
---|---|---|---|---|
aHR (95 % CI) | p value | aHR (95 % CI) | p value | |
Sex female | 0.84 (0.45–1.54) | 0.565 | 0.82 (0.51–1.30) | 0.391 |
Anatomic site of TB | ||||
Pulmonary | Reference | Reference | ||
Extra-pulmonary | 1.10 (0.45–2.67) | 0.835 | 1.36 (0.76–2.44) | 0.295 |
Both | 1.37 (0.32–5.09) | 0.671 | 1.22 (0.38–3.93) | 0.744 |
Prior TB | 1.64 (0.85–3.17) | 0.139 | 1.33 (0.85–2.07) | 0.206 |
TB smear result | ||||
Smear negative | Reference | Reference | ||
Smear positive | 0.41 (0.19–0.90) | 0.027 | 0.57 (0.35–0.93) | 0.025 |
No smear performed | 1.02 (0.33–3.18) | 0.970 | 0.87 (0.42–1.77) | 0.697 |